Company intelligence / Profile preview
StemiGen Therapeutics
Singapore, N/A, Singaporestemigens.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
StemiGen Therapeutics is a Singapore-based biotechnology company focused on harnessing the regenerative properties of human stem cells for chronic wound healing and life enhancement. The company manufactures high-quality mesenchymal stem cells for innovative regenerative medicine applications, collaborating with academic institutions like NTU Singapore to develop therapies for conditions such as osteoarthritis. Product development and animal trials are underway, with plans for future human clinical trials if preclinical results are successful[1][3][5].
- Therapeutic areas
- DermatologyRheumatology
- Modalities
- Human stem cells (primarily mesenchymal stem cells)Stem cell derivatives[1][3][5]
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Nanyang Technological University Singapore (NTU) – research collaboration in regenerative medicine and joint disease[5][6]Osteopore International – industry collaborator in bone regeneration project[6]Plasticell – UK-based collaborator in bone/cartilage projects[6]
Beyond the preview
Go deeper on StemiGen Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on StemiGen Therapeutics.